Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients

<table>(a) The ECG of this 61-year-old patient 3 days after aortocoronary bypass grafting shows atrial fibrillation (HR 129–136/min) and a left bundle branch block. (b) After 2 doses of vernakalant, the patient converted into sinus rhythm (HR 57/min). Bradycardia decreased SvO<sub>2</sub> to 49% and required temporary atrial pacing via the existing epicardial leads.</table>

Critical Care Research and Practice

fig2

Figure 2

Figure 2: Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients 